LECCIÓN

2

MÓDULO

4

Biomarcadores en la esclerosis lateral amiotrófica: neuroimagen
Dr. Alberto Cabrera Zubizarreta

Neurorradiólogo. Unidad de Resonancia Magnética de Osatek. Hospital Universitario Galdakao-Usansolo, Bizkaia

Referencias bibliográficas

  • Barritt AW, Gabel MC, Cercignani M, Leigh PN. Emerging Magnetic Resonance Imaging Techniques and Analysis Methods in Amyotrophic Lateral Sclerosis. Front Neurol. 2018 Dec 4;9:1065. [Pubmed]
  • Dai Z, Chen Y, Yan G, Xiao G, Shen Z, Wu R. Progress of magnetic resonance imaging in amyotrophic lateral sclerosis. Radiol Infect Dis. 2019;6:1-7. Disponible en: [Enlace]
  • Donatelli G, Caldarazzo Ienco E, Costagli M, Migaleddu G, Cecchi P, Siciliano G, Cosottini M. MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis. Neuroimage Clin. 2019;24:101934. [Pubmed]
  • Düzel E, Costagli M, Donatelli G, Speck O, Cosottini M. Studying Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis with 7-T magnetic resonance. Eur Radiol Exp. 2021 Aug 26;5(1):36. [Pubmed]
  • Foerster, BR, Dwamena BA, Petrou M, Carlos RC, Callaghan BC, Churchill, CL, et al. Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Acad Radiol. 2013 Sep;20(9):1099-106. [Pubmed]
  • Grolez G, Moreau C, Danel-Brunaud V, Delmaire C, Lopes R, Pradat PF, et al. The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review. BMC Neurol. 2016 Aug 27;16(1):155. [Pubmed]
  • Kocar TD, Müller HP, Ludolph AC, Kassubek J. Feature selection from magnetic resonance imaging data in ALS: a systematic review. Ther Adv Chronic Dis. 2021 Oct 13;12:20406223211051002. [Pubmed]
  • Mazón M, Vázquez Costa JF, Ten-Esteve A, Martí-Bonmatí L. Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis. Front Neurosci. 2018 Oct 25;12:784. [Pubmed]
  • Menke RA, Agosta F, Grosskreutz J, Filippi M, Turner MR. Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2017 Jan;14(1):11-23. [Pubmed]
  • Müller HP, Dreyhaupt J, Roselli F, Schlecht M, Ludolph AC, Huppertz HJ, Kassubek J. Focal alterations of the callosal area III in primary lateral sclerosis: An MRI planimetry and texture analysis. Neuroimage Clin. 2020;26:102223. [Pubmed]
  • Müller HP, Dreyhaupt J, Roselli F, Schlecht M, Ludolph AC, Huppertz HJ, Kassubek J. Focal alterations of the callosal area III in primary lateral sclerosis: An MRI planimetry and texture analysis. Neuroimage Clin. 2020;26:102223. [Pubmed]
  • Risacher SL, Saykin AJ. Neuroimaging in aging and neurologic diseases. Handb Clin Neurol. 2019;167:191-227. [Pubmed]
  • Shen D, Cui L, Cui B, Fang J, Li D, Ma J. A Systematic Review and Meta-Analysis of the Functional MRI Investigation of Motor Neuron Disease. Front Neurol. 2015 Nov 24;6:246. [Pubmed]
  • Turner MR, Agosta F, Bede P, Govind V, Lulé D, Verstraete E. Neuroimaging in amyotrophic lateral sclerosis. Biomark Med. 2012 Jun;6(3):319-37. [Pubmed]
  • Zejlon C, Nakhostin D, Winklhofer S, Pangalu A, Kulcsar Z, Lewandowski S, et al. Structural magnetic resonance imaging findings and histopathological correlations in motor neuron diseases-A systematic review and meta-analysis. Front Neurol. 2022 Aug 30;13:947347. [Pubmed]